TARSUS PHARMACEUTICALS, INC. (TARS) /
The revenue of TARSUS PHARMACEUTICALS, INC. over the past 8 years
Chart TARSUS PHARMACEUTICALS, INC.: revenue, fiscal 2018–2025 Open the chart →TARSUS PHARMACEUTICALS, INC. reported revenue of $451.36M in fiscal 2025, the latest fiscal year on file. In fiscal 2020 it was $0. Year over year, revenue rose 3 times and fell twice. The largest one-year move was in fiscal 2024: up 949%, from $17.45M to $182.95M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $451.36M |
| 2024ended Dec 31, 2024 | $182.95M |
| 2023ended Dec 31, 2023 | $17.45M |
| 2022ended Dec 31, 2022 | $25.82M |
| 2021ended Dec 31, 2021 | $57.03M |
| 2020ended Dec 31, 2020 | $0 |
| 2019ended Dec 31, 2019 | — |
| 2018 | — |
Fiscal years as TARSUS PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TARSUS PHARMACEUTICALS, INC.
- The profitability of TARSUS PHARMACEUTICALS, INC.
- The cash flow of TARSUS PHARMACEUTICALS, INC.
- The debt of TARSUS PHARMACEUTICALS, INC.
- All of TARSUS PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- NTCTNETSCOUT SYSTEMS INC
- PRVAPrivia Health Group, Inc.
- BWINThe Baldwin Insurance Group, Inc.
- WSCWillscot Holdings Corporation
- EXTRExtreme Networks, Inc.
Not investment advice. This page shows what TARSUS PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.